Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 12:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2233–2256 of 21,991 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Metastatic Breast Cancer
Interventions: Normal Eating, Prolonged Fasting; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Myopia
Interventions: Atropine Sulfate 0.05% Oph Soln, Placebo; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 6 Years to 11 Years
Enrollment: 664 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 13
States / cities: Birmingham, Alabama • Berkeley, California • Fullerton, California + 10 more

Conditions: Suicidal Ideation, Treatment-resistant Depression
Interventions: Accelerated Theta Burst Stimulation; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 70 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 1
States / cities: San Diego, California

Conditions: Postoperative Bleeding, Skin Cancer Face
Interventions: Treatment (tranexamic acid and 1% lidocaine with 1:100,000 epinephrine), Control (1% lidocaine with 1:100,000 epinephrine); Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Suspected Prostate Cancer
Interventions: MRI-guided prostate biopsy using the needle holder frame.; Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 30 Years and older · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Lupus Nephritis
Interventions: None (Observational study); Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 4
States / cities: Baltimore, Maryland • Charlotte, North Carolina • Columbus, Ohio + 1 more

Conditions: Polycythemia Vera
Interventions: Givinostat, Hydroxyurea; Drug
Lead sponsor: Italfarmaco; Industry
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 14
States / cities: Birmingham, Alabama • Redlands, California • Englewood, Colorado + 10 more

Conditions: Refractory Differentiated Thyroid Gland Carcinoma
Interventions: Biospecimen Collection, Cabozantinib, Computed Tomography, Dabrafenib, Magnetic Resonance Imaging, Questionnaire Administration, Trametinib; Procedure · Drug · Other
Lead sponsor: ECOG-ACRIN Cancer Research Group; Network
Eligibility: 18 Years and older
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 307
States / cities: Anchorage, Alaska • Fairbanks, Alaska • Fort Smith, Arkansas + 222 more

Conditions: Alzheimer's Disease (AD), Dementia, Cognitive Decline, Mild Cognitivie Impairment (MCI)
Interventions: Donepezil; Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 65 Years to 100 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Cardiovascular Diseases
Interventions: Healthy Dietary Pattern with Cottonseed Oil, Healthy Dietary Pattern with Fatty Acid-Matched Plant Oils, Healthy Dietary Pattern with PUFA:SFA Ratio-Matched Plant Oil; Other
Lead sponsor: Penn State University; Other
Eligibility: 25 Years to 60 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma, Endometrial Carcinoma, Malignant Female Reproductive System Neoplasm, Ovarian Carcinoma, Ovarian Carcinosarcoma, Stage III Cervical Cancer AJCC v8, Stage III Vaginal Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8, Stage IV Cervical Cancer AJCC v8, Stage IV Vaginal Cancer AJCC v8, Stage IV Vulvar Cancer AJCC v8, Triple-Negative Breast Carcinoma, Uterine Corpus Carcinosarcoma
Interventions: Best Practice, Interview, Supportive Care, Survey Administration, Telephone-Based Intervention; Other · Behavioral
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 11
States / cities: Arcadia, California • Duarte, California • Huntington Beach, California + 8 more

Conditions: Cryotherapy Tubing Placement
Interventions: Tubing Direction; Procedure
Lead sponsor: Children's Hospital of Orange County; Other
Eligibility: 10 Years to 18 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Orange, California

Conditions: Achalasia
Interventions: POEM-F, Conventional POEM; Procedure
Lead sponsor: Chinese University of Hong Kong; Other
Eligibility: 18 Years to 65 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Multiple Sclerosis, Dry Eye Syndromes, Diabetic Retinopathy, Presbyopia, Myopia, Dementia
Interventions: Ocufolin; Dietary Supplement
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 99 Years
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2029
U.S. locations: 1
States / cities: Miami, Florida

Conditions: 24-hydroxylase Deficiency
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: Not listed
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2030
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hip Osteoarthritis, Hip Arthropathy
Interventions: Pericapsular Nerve Block, Fascia Iliaca Nerve Block; Drug
Lead sponsor: LifeBridge Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Diabetes Mellitus, Type 1
Interventions: Allogenic Human Islet Cells, Gastrin 17; Biological · Drug
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years to 68 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Duarte, California

Conditions: Toothbrushing, Gingivitis, Cleft Lip and Palate
Interventions: Toothbrush; Device
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 6 Years to 20 Years
Enrollment: 198 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Adequate Vitamin C Status, Inadequate Vitamin C Status
Interventions: Vitamin C Supplement + Low Vitamin C Diet, Placebo + Low Vitamin C Diet; Dietary Supplement
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Apathy, Loneliness, Reminiscence Therapy
Interventions: Life Story Club; Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 60 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Depression, Anxiety, Pain, Chronic
Interventions: SUSTAIN Monitoring and Care Management; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 65 Years and older
Enrollment: 4,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: X-Linked Myotubular Myopathy
Interventions: ASP2957, Methylprednisolone, Prednisolone, Sirolimus; Genetic · Drug
Lead sponsor: Astellas Gene Therapies; Industry
Eligibility: Up to 36 Months · Male only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Chicago, Illinois • Boston, Massachusetts • Portland, Oregon + 1 more

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Hyperpolarized Xenon-129 MRI (Experimental), Radioactive Xenon-133 scintigraphy (Active Comparator); Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Radiation-Induced Xerostomia and Hyposalivation
Interventions: RXRG001, Placebo; Biological
Lead sponsor: RiboX Therapeutics Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 5
States / cities: Palo Alto, California • Iowa City, Iowa • Baltimore, Maryland + 2 more

Search by objective public record fields.

Fast-Her: Fasting Effects on Breast Cancer Treatment

Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI

Tranexamic Acid in Nasal Mohs Reconstruction

MRI Guided Prostate Biopsy

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

δ in Dementia Clinical Trials

The Effects of Healthy Diets With Plant Oils on Heart and Metabolic Health

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

One Up, One Down: Analyzing Patient Preference on Cryotherapy Machine Tubing Placement

POEM-F for Achalasia International Study

Clinical Applications of Advanced Ophthalmic Imaging

24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry

The Pericapsular Nerve Block in Total Hip Arthroplasty

Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes

Effectiveness of Dual Light Electric Toothbrush vs. Manual Toothbrush in Orthodontic Patients Undergoing Oral Surgery

Anti-inflammatory Activities of Vitamin C Supplementation on the Gut Barrier Function in Adults With Obesity

A Virtual Life Story Club Intervention to Improve Loneliness and Apathy in Community-Dwelling Older Adults

Evaluation of the PACE/PACENET BHL Clinical Program

Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators

Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy

Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1